Results on preemptive or prophylactic treatment of lamivudine in HBsAg (+) renal allograft recipients: Comparison with salvage treatment after hepatic dysfunction with HBV recurrence

Transplantation

Volumn 71, Issue 3, 2001, Pages 387-394

  Han, Duck J ^a   Kim, Tae H ^a   Park, Su K ^a   Lee, Sang K ^a   Kim, Soon B ^a   Yang, Won S ^a   Park, Jung S ^a   Jung, Jae G ^a   Yu, Eun S ^a   Kim, Song C ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS; HUMAN; HUMAN TISSUE; KIDNEY ALLOGRAFT; LIVER BIOPSY; LIVER DYSFUNCTION; LIVER FUNCTION; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE; RISK FACTOR; SALVAGE THERAPY; VIRUS REPLICATION;

EID: 0035865376     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200102150-00008     Document Type: Article

References (29)

1. Hepatocellulor carcinoma and hepatitis B virus: A prospective study of 22707 men in Taiwan
2. Hepatitis B; global importance and need for control
3. Clinicopathologic course hepatitis B infection in antigen carriers following living-related renal transplantation
4. Hepatitis B virus and hepatitis B-related infection in renal transplant recipients
5. The significance and implications of hepatitis B infection in renal transplant recipients
6. Antiviral therapy in chronic hepatitis B infection
7. Acute renal failure in kidney transplant patients treated with infection alpha 26 for hepatitis C
8. A-one year trial of lamivudine for chronic hepatitis B
9. Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation
10. The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection
11. Classification of chronic hepatitis: Diagnosis, grading and staging
12. The clinical and pathologic course of hepatitis B liver disease in renal transplant recipients
13. Chronic hepatitis B in asymptomatic homosexual men with antibodies 50 human immunodeficiency virus
14. Hepatitis B virus markers in children with acute leukemia
15. Clinical aspect of hepatitis virus infection
16. Hepatitis B surface antigen gene expression is regulated by sex steroids and glucocorticoids in transgenic mice
17. Impact of hepatitis on renal transplantation
18. Analysis of T-lymphocyte subset in cytomegalovirus mononucleosis
19. Liver disease in recipients of long functioning renal allografts
20. Successful renal transplantation in patients positive for hepatitis B antigen
21. The increased risk of fatal liver disease in renal transplant patients who are hepatitis B antigen and/or HBV DNA positive
22. Interferon alpha for recurrent hepatitis B injection after liver transplantation
23. Effectiveness of adenine arabinside 5-monophosphate in kidney transplant recipients with chronic active hepatitis B
24. Efficacy of limivudine re-treatment in a patient with hepatitis B virus (HBV) recurrence after liver transplantation and HBV-DNA breakthrough during the first treatment
25. Orthotopic liver transplantation for patients with hepatitis B virus related liver disease
26. Lamivudine prophylaxis in liver transplantation for hepatitis B in Asians
27. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine
28. Hepatitis B virus resistance lamivudine given for recurrent infection after orthotopic liver transplantation